FDA Launches NAIN Program to Accelerate Neuroscience Product Development
Start here
The FDA has launched the Neuroscience Advancement and Innovation Nexus (NAIN), a new program to coordinate the development of medical products for brain and nervous system conditions. Its first initiative is the Alzheimer's Prevention Accelerator, which will focus on the prevention of Alzheimer's disease. The program marks a coordinated agency effort to advance treatments in an area of significant unmet need. Details on how the accelerator will operate, which stakeholders will participate, and what specific development activities come first have not yet been spelled out.
Written by a model from the reports · updated 2 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- fda.govFDA Launches New Program to Advance Neuroscience Medical Product Development
The FDA has launched the Neuroscience Advancement and Innovation Nexus (NAIN) to coordinate development of medical products for brain and nervous system conditions. Its first initiative, the Alzheimer's Prevention Accelerator, will focus on Alzheimer's disease prevention.
Heat trend for this story
Not enough continuous observation yet to draw a trend.